Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03889522 · ClinicalTrials.gov registry record
The Influence of Non-Caloric Artificial Sweeteners on Youth With Type 1 Diabetes
A clinical trial, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- 21
- Enrollment target
NCT03889522: Completed study, sponsored by Medical College of Wisconsin.
NCT03889522 is a clinical trial that has completed, run by Medical College of Wisconsin. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03889522 has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
The investigators aim to further the understanding of environmental factors that may underlie variations in body composition seen in youth with Type 1 diabetes (T1D). Non-caloric artificial sweeteners, broadly consumed in many individuals with T1D, are a modifiable dietary factor that may be associated with negative health outcomes, particularly those relevant to the future risk of diabetes-related complications. Investigators will measure body composition (the amount of fat and muscle in the body and where the fat is stored) using a bioelectrical impedance analysis machine and DEXA scanner. Blood will be drawn for the following labs: HbA1c, lipid panel, comprehensive metabolic panel and leptin. Participants will also answer questions about their diets and consumption of artificial sweeteners.
Primary Outcome
To quantify artificial sweetener consumption patterns in a cohort of youth with T1D through novel food frequency questionnaires (Non-caloric artificial sweetener Food Frequency Questionnaire for Food and the Non-caloric artificial sweetener Food Frequency Questionnaire for Beverages) and bioassay
Interventions
- DIAGNOSTIC_TEST Blood draw
- DIAGNOSTIC_TEST Bioelectrical Impedance Analysis
- DIAGNOSTIC_TEST Total Body Dual-energy X-ray Absorptiometry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2021-02-25 |
What the finished NCT03889522 record still lists
NCT03889522 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Blood draw is the first listed.
NCT03889522 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03889522 about?
NCT03889522 is a clinical study titled "The Influence of Non-Caloric Artificial Sweeteners on Youth With Type 1 Diabetes". The investigators aim to further the understanding of environmental factors that may underlie variations in body composition seen in youth with Type 1 diabetes (T1D). Non-caloric artificial sweeteners, broadly consumed in many individuals with T1D, are a modifiable dietary factor that may be associa...
What is the current status of trial NCT03889522?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2019-05-01. Estimated completion is 2021-02-25.
What interventions are being tested in trial NCT03889522?
The interventions under investigation include: Blood draw (DIAGNOSTIC_TEST), Bioelectrical Impedance Analysis (DIAGNOSTIC_TEST), Total Body Dual-energy X-ray Absorptiometry (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03889522?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI